We’re pleased to announce the publication, in Pharmaceutical Medicine, of another piece of our game-changing original #research in medical affairs and pharmaceuticals strategy.

Covid-19 Interventional Clinical Trials Analysis – 06/04/2020

Since the emergence of Covid-19, there has been a swift and concerted response by research teams around the world to find new treatments for this pandemic viral illness. The team at Medialis have analysed the status of all clinical studies.

read more

Learn how to Overcome Observational Clinical Study (Patient Registry) Development Challenges

Observational cohort clinical studies, or patient registries, are common studies that generate data required not only by regulators, but, also payers and prescribers. While patient registries seem simple,..

read more

MAPS EMEA 2019 Annual Meeting: Removing Our Own Barriers: Unlocking Medical’s Full Potential


Come see why everyone is so passionate about the future of medical: Unlocking Medical’s Full Potential.

read more

A novel method for observing proportional group awareness and consensus

Current healthcare professional consensus-generating methodologies work by forcing consensus, which risks corrupting original opinions and often fails to assess prior expert awareness.

read more

Partnership with Fight Cancer Global

We are glad to announce that the Medialis not for profit branch has joined Fight Cancer Global as a partner. Fight Cancer global is a fantastic worldwide initiative to create a network platform within the healthcare space.

read more

Factors influencing the generation of evidence

The results of this study indicate that privately-funded international rare disease patient registries produce significantly more evidence than their publicly-funded counterparts.

read more

We use cookies to give you the best possible experience. By using our website, you're agreeing to our use of cookies. To find out more read our cookie policy